U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Colorectal Adenocarcinoma

MedGen UID:
1705592
•Concept ID:
C5206560
•
Neoplastic Process

Definition

The reemergence of colorectal adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Colorectal Adenocarcinoma

Professional guidelines

PubMed

Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma.
Martínez-Monge R, Nag S, Martin EW
Cancer 1999 Jul 15;86(2):236-47. doi: 10.1002/(sici)1097-0142(19990715)86:2<236::aid-cncr7>3.0.co;2-9. PMID: 10421259
Treatment of metastatic colorectal adenocarcinoma with fluorouracil and high-dose leucovorin: a pilot study.
Hsieh RK, Fan S, Lin JK, Liang CL, Lin TC, Tzeng CH, Hsu H, Chen PM
Zhonghua Yi Xue Za Zhi (Taipei) 1989 Mar;43(3):159-64. PMID: 2790583

Recent clinical studies

Etiology

Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
Terezakis S, Morikawa L, Wu A, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA
Ann Surg Oncol 2015 Jul;22(7):2168-78. Epub 2015 Jan 29 doi: 10.1245/s10434-014-4271-8. PMID: 25631062Free PMC Article
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
Alektiar KM, Zelefsky MJ, Paty PB, Guillem J, Saltz LB, Cohen AM, Minsky BD
Int J Radiat Oncol Biol Phys 2000 Aug 1;48(1):219-26. doi: 10.1016/s0360-3016(00)00634-9. PMID: 10924992
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE
Dis Colon Rectum 2000 Jun;43(6):759-67; discussion 767-70. doi: 10.1007/BF02238010. PMID: 10859074
Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma.
Martínez-Monge R, Nag S, Martin EW
Cancer 1999 Jul 15;86(2):236-47. doi: 10.1002/(sici)1097-0142(19990715)86:2<236::aid-cncr7>3.0.co;2-9. PMID: 10421259
Surgical resection of locally recurrent colorectal adenocarcinoma.
Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, Granger F, Houvenaeghel G
Br J Surg 1998 Mar;85(3):372-6. doi: 10.1046/j.1365-2168.1998.00583.x. PMID: 9529496

Diagnosis

miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A
Mol Diagn Ther 2017 Aug;21(4):453-464. doi: 10.1007/s40291-017-0270-3. PMID: 28405803
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE
Dis Colon Rectum 2000 Jun;43(6):759-67; discussion 767-70. doi: 10.1007/BF02238010. PMID: 10859074
Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M, Chaiwatanarat T, Saesow N, Thitathan S, Voravud N
Eur J Nucl Med 1996 Jun;23(6):624-30. doi: 10.1007/BF00834523. PMID: 8662095
Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM Jr, Bass BL, Bates HR, Chandeysson PL, Harmon JW
Am J Surg 1993 Jan;165(1):137-42; discussion 142-3. doi: 10.1016/s0002-9610(05)80417-9. PMID: 8418688
Radioimmunoscintigraphy of recurrent colorectal carcinoma using 111In-labelled murine monoclonal antibody B72.3: a comparison with contrast-enhanced computed tomography.
Kmiot WA, Stonelake P, Sagar G, Donovan IA, Neoptolemos JP, Notghi A, Harding LK
Nucl Med Commun 1993 Sep;14(9):788-91. doi: 10.1097/00006231-199309000-00008. PMID: 8233244

Therapy

Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
Rothenberg ML, LaFleur B, Levy DE, Washington MK, Morgan-Meadows SL, Ramanathan RK, Berlin JD, Benson AB 3rd, Coffey RJ
J Clin Oncol 2005 Dec 20;23(36):9265-74. doi: 10.1200/JCO.2005.03.0536. PMID: 16361624
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
Alektiar KM, Zelefsky MJ, Paty PB, Guillem J, Saltz LB, Cohen AM, Minsky BD
Int J Radiat Oncol Biol Phys 2000 Aug 1;48(1):219-26. doi: 10.1016/s0360-3016(00)00634-9. PMID: 10924992
Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma.
Martínez-Monge R, Nag S, Martin EW
Cancer 1999 Jul 15;86(2):236-47. doi: 10.1002/(sici)1097-0142(19990715)86:2<236::aid-cncr7>3.0.co;2-9. PMID: 10421259
Use of combined intraoperative radiotherapy and 125I brachytherapy in incompletely resected recurrent colorectal carcinoma.
Martínez-Monge R, Nag S
Rev Med Univ Navarra 1999 Jan-Mar;43(1):11-4. PMID: 10386341
Treatment of metastatic colorectal adenocarcinoma with fluorouracil and high-dose leucovorin: a pilot study.
Hsieh RK, Fan S, Lin JK, Liang CL, Lin TC, Tzeng CH, Hsu H, Chen PM
Zhonghua Yi Xue Za Zhi (Taipei) 1989 Mar;43(3):159-64. PMID: 2790583

Prognosis

miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A
Mol Diagn Ther 2017 Aug;21(4):453-464. doi: 10.1007/s40291-017-0270-3. PMID: 28405803
Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
Terezakis S, Morikawa L, Wu A, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA
Ann Surg Oncol 2015 Jul;22(7):2168-78. Epub 2015 Jan 29 doi: 10.1245/s10434-014-4271-8. PMID: 25631062Free PMC Article
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
Alektiar KM, Zelefsky MJ, Paty PB, Guillem J, Saltz LB, Cohen AM, Minsky BD
Int J Radiat Oncol Biol Phys 2000 Aug 1;48(1):219-26. doi: 10.1016/s0360-3016(00)00634-9. PMID: 10924992
Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, Birnbaum EH, Fleshman JW, Kodner IJ, Read TE
Dis Colon Rectum 2000 Jun;43(6):759-67; discussion 767-70. doi: 10.1007/BF02238010. PMID: 10859074
Surgical resection of locally recurrent colorectal adenocarcinoma.
Delpero JR, Pol B, Le Treut P, Bardou VJ, Moutardier V, Hardwigsen J, Granger F, Houvenaeghel G
Br J Surg 1998 Mar;85(3):372-6. doi: 10.1046/j.1365-2168.1998.00583.x. PMID: 9529496

Clinical prediction guides

miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.
Kontos CK, Tsiakanikas P, Avgeris M, Papadopoulos IN, Scorilas A
Mol Diagn Ther 2017 Aug;21(4):453-464. doi: 10.1007/s40291-017-0270-3. PMID: 28405803
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma.
Rothenberg ML, LaFleur B, Levy DE, Washington MK, Morgan-Meadows SL, Ramanathan RK, Berlin JD, Benson AB 3rd, Coffey RJ
J Clin Oncol 2005 Dec 20;23(36):9265-74. doi: 10.1200/JCO.2005.03.0536. PMID: 16361624
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.
Alektiar KM, Zelefsky MJ, Paty PB, Guillem J, Saltz LB, Cohen AM, Minsky BD
Int J Radiat Oncol Biol Phys 2000 Aug 1;48(1):219-26. doi: 10.1016/s0360-3016(00)00634-9. PMID: 10924992
Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M, Chaiwatanarat T, Saesow N, Thitathan S, Voravud N
Eur J Nucl Med 1996 Jun;23(6):624-30. doi: 10.1007/BF00834523. PMID: 8662095
Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
Petersen BM Jr, Bass BL, Bates HR, Chandeysson PL, Harmon JW
Am J Surg 1993 Jan;165(1):137-42; discussion 142-3. doi: 10.1016/s0002-9610(05)80417-9. PMID: 8418688

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...